• IM Cannabis agreed to sell IMC Holdings to Slil.com Holding, shifting its European-focused assets while keeping its Israeli medical cannabis operations.
• Slil previously paid CAD 3 million in advances; it will also assume retained liabilities capped at about CAD 9.4 million, subject to adjustments.
• The deal is expected to lift shareholders’ equity by about CAD 3 million, cut liabilities, improve working capital, and simplify the structure.
• Closing requires completion of a pre-closing reorganization, a tax certificate from the Israel Tax Authority, and other consents.
• The outside date for closing is Sept. 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IM Cannabis Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608170632PR_NEWS_USPR_____LN27425) on August 17, 2026, and is solely responsible for the information contained therein.